Recombinant YWHAE anticorps (full length)
Aperçu rapide pour Recombinant YWHAE anticorps (full length) (ABIN7877579)
Antigène
Voir toutes YWHAE AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- full length
-
Fonction
- Recombinant YWHAE Antibody / 14-3-3E
-
Purification
- Protein A/G affinity
-
Immunogène
- Recombinant human full-length protein was used as the immunogen for the recombinant YWHAE antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant YWHAE antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the recombinant YWHAE antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- YWHAE (14-3-3 epsilon (YWHAE))
-
Autre désignation
- YWHAE
-
Sujet
- Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathway. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. It interacts with CDC25 phosphatases, RAF1 and IRS1 proteins, suggesting its role in diverse biochemical activities related to signal transduction, such as cell division and regulation of insulin sensitivity. It has also been implicated in the pathogenesis of small cell lung cancer. The YWHAE gene which encodes 14-3-3E has also been identified as a possible susceptibility gene for schizophrenia.
-
UniProt
- P62258
-
Pathways
- Neurotrophin Signaling Pathway, Myometrial Relaxation and Contraction, M Phase
Antigène
-